PTL was found to be particularly cytotoxic to prostatic cancer stem cells (or tumor-initiating cells, TICs), thus underscoring ELK1’s role in early PCa tumorigenesis and how its targeting may be a potential approach [172]. Here, ELK1 is linked to prostate cancer.